Why is comorbidity the norm, not the exception, in ADHD?

PostedNovember 20, 2025

UpdatedNovember 21, 2025

ByMy Patient Advice

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Comorbidity is now recognised as the rule, not the exception, among adults with ADHD. Most individuals experience at least one additional psychiatric or medical condition. According to the 2025 NHS ADHD Taskforce report and NICE guidance (NG87), overlapping symptoms, shared neurobiological mechanisms, and psychosocial stress factors all contribute to the high comorbidity rates seen in adult ADHD. This complexity often makes accurate diagnosis and treatment more challenging, as noted by the Royal College of Psychiatrists (RCPsych).

Prevalence and types of comorbidities

Recent NHS and NICE data estimate that between 60% and 80% of adults with ADHD live with at least one other psychiatric or physical health condition. The most common comorbidities include anxiety disorders such as generalised anxiety and panic disorder, which affect around half of adults with ADHD. Depressive disorders occur in up to 50% of cases, while bipolar disorder affects roughly 7–17%. The overlap with autism spectrum disorder is also well documented and now explicitly recognised in NICE guidance. Substance use, sleep disturbance, eating difficulties, and chronic pain are also significantly more common than in the general population according to NHS data.

Why comorbidity is so common: neurobiology and psychosocial explanations

A 2025 meta-analysis in PubMed and RCPsych guidance report that ADHD shares genetic and neurobiological pathways with anxiety, depression, and autism. These include alterations in dopamine and noradrenaline circuits, which influence mood, motivation, and focus. Neuroimaging studies have identified overlapping areas of cortical thinning and disrupted attention networks across these conditions. Psychosocial stressors, including chronic underachievement, work stress, and relationship strain, also increase the risk of developing secondary mental health problems. When ADHD remains untreated, long-term emotional distress often leads to anxiety and depression.

Diagnostic and clinical implications

Both NICE and RCPsych highlight that symptom overlap contributes to frequent misdiagnosis or diagnostic delay. For example, inattentive ADHD can be mistaken for depression, while mood instability may be misattributed to bipolar disorder. UK ADHD services are often split between neurodevelopmental and general mental health pathways, making it difficult for clinicians to assess complex presentations. NICE therefore recommends multidisciplinary assessment, involving structured interviews, collateral history, and evaluation across different life settings to capture the full picture.

Evidence-based management strategies

Effective management must address ADHD and its comorbidities together. NICE guidance and NHS England both recommend integrated care pathways that combine medication, psychological support such as CBT, and lifestyle strategies. Treating coexisting conditions simultaneously improves overall functioning and reduces relapse risk, as highlighted in a 2024 Lancet Psychiatry review. Specialist “complex case” clinics and neurodivergent adult pathways are also being piloted in the UK to improve outcomes for adults with multiple diagnoses.

Key takeaway

According to NICE, NHS England, and the Royal College of Psychiatrists, high comorbidity in ADHD stems from shared neurobiological vulnerabilities and life stress factors that amplify one another over time. Recognising ADHD as a condition that rarely exists in isolation allows for earlier detection, more accurate diagnosis, and better integrated care. Comorbidity may be the norm, but with coordinated treatment and long-term support, adults can experience meaningful improvements in stability, wellbeing, and daily function.

Harriet Winslow, BSc

Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.